ClinicalTrials.gg
CompletedNCT05513898PILOLASUpdated Jul 1, 2024

Treatment of Pilonidal Cyst With Holmium Laser

An observational study in Pilonidal Cyst, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-07-01.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
231
Ages
18 Years and older
Sex
All
01

Study summary

Observational study on the treatment of pilonidal cyst with Holmium laser. Single-centre retrospective study of medical data from patients' medical records

Read the detailed description

From the medical records of a series of patients treated for pilonidal cysts with Holmium laser:

  1. Primary objective: to assess the rate of healing at 1 month after Holmium laser treatment (healing being defined as no dressing)
  2. Secondary objectives: to assess the following:

    • Healing rate at last follow-up (1 month after surgery)
    • Recurrence rate at last follow-up (1 month after surgery)
    • Consumption of >1 level analgesics in the week and month following the procedure
    • Duration of nursing care
02

Conditions studied

  • Pilonidal Cyst

Browse trials for

03

In context

Pilonidal Sinus

109 studies on the registry are indexed under Pilonidal Sinus; 31 are open to participants now.

This study's enrollment of 231 is above the median of 151 across 35 observational studies indexed under Pilonidal Sinus.

Browse Pilonidal Sinus studies →

Lead sponsor

GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 204 studies on the registry; 97 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The patients participating in the study were operated on at the centre between AUGUST and NOVEMBER 2020. The study is based solely on a review of the medical records of these patients. No further evaluation is planned.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient aged 18 years or older, who has been informed of the research;
  • Patient with a pilonidal cyst treated with Holmium Laser during a scheduled procedure.

Exclusion criteria

Exclusion Criteria:

  • Patient under legal protection, guardianship or curatorship;
  • Patient who has indicated his opposition to the use of his data.
  • Patient undergoing emergency surgery for an abscess
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
231 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Healing rate

    explanatory analysis of the healing rate at Month 1

    Time frame: Month 1

07

Study locations

1 site
  • Clinique de la Sauvegarde
    Lyon, 69009, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05513898
Responsible party
Sponsor
First posted
Aug 24, 2022
Start date
Apr 1, 2022
Primary completion
Jan 31, 2023
Completion
Jan 31, 2023
Last update
Jul 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion